The Effect of Being Pregnant during Respiratory Pandemics: A Comparison between 2009/10 Flu and 2020/21 COVID-19 Pandemic in Brazil

Carregando...
Imagem de Miniatura
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2022
Título da Revista
ISSN da Revista
Título do Volume
Editora
MDPI
Autores
ROSA JUNIOR, Elias Ribeiro
MONROY, Nataly Adriana Jimenez
GODOI, Luciana Graziela de
MATTOS, Bruna Rodrigues de
RODRIGUES, Agatha Sacramento
Citação
VACCINES, v.10, n.8, article ID 1202, 11p, 2022
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Pregnant women undergo physiological changes that make them a challenging group of patients during pandemic respiratory diseases, as previously found during H1N1 2009 pandemic and recently ratified in COVID-19 pandemic. We conducted a retrospective cohort analysis on 5888 hospitalized women for H1N1 flu pandemic (2190 pregnant and 3698 non-pregnant) and 64,515 hospitalized women for COVID-19 pandemic (5151 pregnant and 59,364 non-pregnant), from the Brazilian national database, to compare demographic profile, clinical aspects, and mortality in childbearing aged women during both pandemics. Additionally, the effect of being pregnant was compared between both pandemics. In both pandemics, pregnant women were younger than non-pregnant women. Overall, pregnant women had lower frequencies of comorbidities and were less symptomatic. Among hospitalized women, pregnant women presented lower mortality rates than non-pregnant women (9.7% vs. 12.6%, p = 0.002 in the H1N1 pandemic and 9.7% vs. 17.4%, p < 0.001 in the COVID-19 pandemic) and this difference was statistically more pronounced in the COVID-19 pandemic, even after balancing pregnant and non-pregnant groups regarding age and chronic diseases.
Palavras-chave
pregnancy, Influenza A virus, H1N1 subtype, COVID-19, mortality
Referências
  1. [Anonymous], 2013, Obstet Gynecol, V121, P1138, DOI 10.1097/01.AOG.0000429660.31589.6a
  2. Austin PC, 2011, MULTIVAR BEHAV RES, V46, P399, DOI 10.1080/00273171.2011.568786
  3. Boon HL, 2011, J OBSTET GYN INDIA, V61, P386, DOI 10.1007/s13224-011-0055-2
  4. Breslow NE, 1996, J AM STAT ASSOC, V91, P14, DOI 10.2307/2291379
  5. Callaghan WM, 2015, OBSTET GYNECOL, V126, P486, DOI 10.1097/AOG.0000000000000996
  6. Chen HJ, 2020, LANCET, V395, P809, DOI 10.1016/S0140-6736(20)30360-3
  7. Dolan GP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041638
  8. Greifer N., **DATA OBJECT**
  9. Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0
  10. Kfouri R.A., 2013, EINSTEIN-SAO PAULO
  11. Khan DSA, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18115613
  12. Leal MD, 2020, REV SAUDE PUBL, V54, DOI 10.11606/s1518-8787.2020054001458
  13. Lenzi L, 2012, CAD SAUDE PUBLICA, V28, P395, DOI 10.1590/S0102-311X2012000200018
  14. Lim C, 2015, PUBLIC HEALTH, V129, P769, DOI 10.1016/j.puhe.2015.04.013
  15. Mak TK, 2008, LANCET INFECT DIS, V8, P44, DOI 10.1016/S1473-3099(07)70311-0
  16. McDonald Chloe R, 2020, Front Glob Womens Health, V1, P564560, DOI 10.3389/fgwh.2020.564560
  17. Ministerio da Saude, 2016, CONS NAC SAUD RES 51
  18. Ministerio da Saude Secretaria de Vigilancia em Saude, 2020, GUIA VIG EP EM SAUD
  19. Ministerio da Saude. Secretaria de Vigilancia em Saude Departamento de Analise de Situacao em Saude, 2009, GUIA VIG OB MAT A
  20. Paganoti CD, 2022, VACCINES-BASEL, V10, DOI 10.3390/vaccines10050749
  21. Paganoti CD, 2022, VACCINES-BASEL, V10, DOI 10.3390/vaccines10020206
  22. R Development Core Team, 2022, R LANG ENV STAT COMP
  23. ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41
  24. Saraceni V, 2010, EPIDEMIOL SERV SAUDE, V19, P339
  25. Schwartz DA, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12020194
  26. Selim M, 2020, CUREUS J MED SCIENCE, V12, DOI 10.7759/cureus.8888
  27. Serra F.E., 2021, MEDRXIV, DOI [10.1101/2021.07.27.21261163, DOI 10.1101/2021.07.27.21261163]
  28. Teixeira C.T., 2015, HUPE RIO JAN, V14, P6, DOI [10.12957/rhupe.2015.16214, DOI 10.12957/RHUPE.2015.16214]
  29. Thompson JL, 2020, AM J REPROD IMMUNOL, V84, DOI 10.1111/aji.13339
  30. Vibrans AC, 2020, SCI AGR, V77, DOI [10.1590/1678-992x-2018-0036, 10.1590/1678-992X-2018-0036]
  31. Francisco RPV, 2021, CLINICS, V76, DOI 10.6061/clinics/2021/e3120
  32. WASSERTHEIL S, 1970, BIOMETRICS, V26, P588, DOI 10.2307/2529115